Found 40 matching trials
Study of Everolimus in de Novo Renal Transplant Recipients
NAIn the present study, the investigators propose a conversion scheme with 50...
Location
Hospital São João de Deus/Fundação Geraldo Corrêa
Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients
PHASE3The purpose of this study was to determine whether an early Calcineurin Inh...
Location
Novartis Investigative Site
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
PHASE4Protocol Title: Randomized open label study comparing the metabolic control...
Location
Stanford university Hospital and Clinics
Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
PHASE4This three-arm study will evaluate the efficacy and safety of various dosin...
Location
Multiple Locations
SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
PHASE4A controlled, randomized, open-label, multicenter study evaluating if early...
Location
Novartis Investigative Site
Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function
PHASE4The purpose of this trial is to ascertain whether the withdrawal of calcine...
Location
University Hospital Birmingham NHS Foundation Trust
RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency
PHASE3The purpose of the study is to assess the effect of everolimus initiation t...
Location
Novartis Investigational Site
Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring
PHASE4The overall goal of this study is to improve cardiovascular outcomes in tra...
Location
Kidney Health Center
Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.
PHASE4Calcineurin inhibitors (CNI), a potent immunosuppressive drug used in kidne...
Location
Novartis Investigative Site
Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation
PHASE4Clinical Problem: Renal insufficiency after heart transplantation caused by...
Location
Medizinische Universitätsklinik, Kardiologie